Circulating tumour DNA—looking beyond the blood
Over the past decade, various liquid biopsy techniques have emerged as viable alternatives
to the analysis of traditional tissue biopsy samples. Such surrogate 'biopsies' offer numerous …
to the analysis of traditional tissue biopsy samples. Such surrogate 'biopsies' offer numerous …
Liquid biopsy in gliomas: A RANO review and proposals for clinical applications
R Soffietti, C Bettegowda, IK Mellinghoff… - Neuro …, 2022 - academic.oup.com
Background There is an extensive literature highlighting the utility of blood-based liquid
biopsies in several extracranial tumors for diagnosis and monitoring. Methods The RANO …
biopsies in several extracranial tumors for diagnosis and monitoring. Methods The RANO …
Current perspectives on diffuse midline glioma and a different role for the immune microenvironment compared to glioblastoma
CJ Pachocki, EM Hol - Journal of neuroinflammation, 2022 - Springer
Diffuse midline glioma (DMG), formerly called diffuse intrinsic pontine glioma (DIPG), is a
high-grade malignant pediatric brain tumor with a near-zero survival rate. To date, only …
high-grade malignant pediatric brain tumor with a near-zero survival rate. To date, only …
Circulating histones to detect and monitor the progression of cancer
Liquid biopsies have emerged as a minimally invasive cancer detection and monitoring
method, which could identify cancer-related alterations in nucleosome or histone levels and …
method, which could identify cancer-related alterations in nucleosome or histone levels and …
The current landscape of glioblastoma biomarkers in body fluids
Simple Summary Glioblastoma is a highly aggressive brain cancer, and early detection and
accurate diagnosis are crucial for effective treatment. Traditional diagnostic methods have …
accurate diagnosis are crucial for effective treatment. Traditional diagnostic methods have …
[HTML][HTML] Therapeutic avenues for targeting treatment challenges of diffuse midline gliomas
A Noon, S Galban - Neoplasia, 2023 - Elsevier
Diffuse midline glioma (DMG) is the leading cause of brain tumor-related deaths in children.
DMG typically presents with variable neurologic symptoms between ages 3 and 10 …
DMG typically presents with variable neurologic symptoms between ages 3 and 10 …
[HTML][HTML] The promise of metabolic imaging in diffuse midline glioma
S Lovibond, AN Gewirtz, L Pasquini, S Krebs… - Neoplasia, 2023 - Elsevier
Recent insights into histopathological and molecular subgroups of glioma have
revolutionized the field of neuro-oncology by refining diagnostic categories. An emblematic …
revolutionized the field of neuro-oncology by refining diagnostic categories. An emblematic …
Advances on liquid biopsy analysis for glioma diagnosis
P Skouras, M Markouli, T Kalamatianos, G Stranjalis… - Biomedicines, 2023 - mdpi.com
Gliomas comprise the most frequent primary central nervous system (CNS) tumors,
characterized by remarkable genetic and epigenetic heterogeneity, difficulty in monitoring …
characterized by remarkable genetic and epigenetic heterogeneity, difficulty in monitoring …
[HTML][HTML] Translational considerations for immunotherapy clinical trials in pediatric neuro-oncology
JB Foster, MM Alonso, E Sayour, TB Davidson… - Neoplasia, 2023 - Elsevier
While immunotherapy for pediatric cancer has made great strides in recent decades,
including the FDA approval of agents such as dinutuximab and tisgenlecleucel, these …
including the FDA approval of agents such as dinutuximab and tisgenlecleucel, these …
Cell-free tumor DNA (cf-tDNA) liquid biopsy: Current methods and use in brain tumor immunotherapy
Gliomas are tumors derived from mutations in glial brain cells. Gliomas cause significant
morbidity and mortality and development of precision diagnostics and novel targeted …
morbidity and mortality and development of precision diagnostics and novel targeted …